Skip to main content

Mike Yee

Analyst

UBS

Equibles does not estimate personal net worth.

About Mike Yee

Mike Yee is recorded as Analyst at UBS. Mike Yee has spoken on 2 earnings calls across 2 companies, most recently for Gilead Sciences, Inc. on May 7, 2026. Those appearances were for Gilead Sciences, Inc. (GILD) and Vertex Pharmaceuticals Inc (VRTX). The companies whose calls Mike Yee spoke on are classified in the Healthcare sector.

Mike Yee on recent calls

“On GS3242, you had some great data at CROI recently. Your competitor seems to think that they are ahead, I think, publicly stating 20-30 type time to market, and you're saying 20-31 to 33.”
Analyst — UBS, Gilead Sciences, Inc. Q1 FY2026 Earnings Call ·
“On POVI, do you believe that you're, on the efficacy standpoint, that your differentiation on EGFR will be able to come through over 9, 12, or 24 months versus, say, ATSUCA, which I think is presenting their EGFR nine-month data, I think, next month, and then their two-year data coming up?”
Analyst — UBS, Vertex Pharmaceuticals Inc / Ma Q1 FY2026 Earnings Call ·

Affiliation history

  • UBS

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity